Yong-Soo Kim Selected Research

Hypertrophy

3/2022	Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice.
1/2006	Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Soo Kim Research Topics

Disease

16	Chronic Renal Insufficiency 06/2022 - 01/2013
8	Albuminuria 01/2019 - 04/2011
7	Inflammation (Inflammations) 03/2022 - 11/2009
7	Chronic Kidney Failure (Chronic Renal Failure) 09/2019 - 03/2011
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 04/2011
6	Proteinuria 12/2021 - 09/2013
6	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 06/2014
6	Neoplasms (Cancer) 01/2020 - 11/2010
5	Fibrosis (Cirrhosis) 03/2022 - 06/2002
4	Infections 09/2019 - 06/2005
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2009
3	Water Intoxication 12/2019 - 01/2016
3	Left Ventricular Dysfunction 11/2019 - 08/2012
3	Arteriovenous Fistula 07/2019 - 11/2015
3	Renal Insufficiency (Renal Failure) 01/2019 - 04/2015
3	Wounds and Injuries (Trauma) 01/2016 - 01/2014
2	Myocardial Infarction 06/2022 - 01/2022
2	Stroke (Strokes) 06/2022 - 01/2022
2	Hypertrophy 03/2022 - 01/2006
2	Insulin Resistance 03/2022 - 01/2018
2	Heart Failure 01/2022 - 11/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2011
2	Hyperuricemia 01/2020 - 01/2019
2	Oliguria 01/2020 - 01/2016
2	Body Weight (Weight, Body) 01/2019 - 01/2018
2	Hemorrhage 08/2018 - 01/2011
2	Lymphoma (Lymphomas) 01/2018 - 01/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2017 - 03/2011
2	Anemia 01/2017 - 06/2016
2	Hypertension (High Blood Pressure) 06/2015 - 06/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2014 - 01/2012
2	Venous Thrombosis (Deep-Vein Thrombosis) 07/2014 - 03/2013
2	Secondary Hyperparathyroidism 01/2012 - 01/2006
2	Cardiomegaly (Heart Hypertrophy) 01/2012 - 01/2006
2	Lupus Nephritis 03/2011 - 03/2011
1	Diabetic Cardiomyopathies 03/2022
1	Death (Near-Death Experience) 01/2022
1	Unstable Angina 01/2022
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021
1	Inappropriate ADH Syndrome (SIADH) 06/2020
1	Hyponatremia 06/2020
1	Tumor Lysis Syndrome 01/2020
1	Bone Marrow Failure Disorders 01/2020
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2020

Drug/Important Bio-Agent (IBA)

11	CreatinineIBA 01/2021 - 06/2002
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2006
6	AdiponectinIBA 01/2021 - 01/2016
4	LipidsIBA 03/2022 - 06/2016
4	Uric Acid (Urate)IBA 01/2021 - 02/2012
4	hydroxide ionIBA 12/2019 - 01/2016
3	Triglycerides (Triacylglycerol)IBA 03/2022 - 06/2012
3	AdipoRonIBA 03/2022 - 01/2018
3	Nonesterified Fatty Acids (NEFA)IBA 03/2022 - 06/2012
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2019 - 06/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 11/2009
2	CalciumIBA 06/2022 - 12/2018
2	omega-Chloroacetophenone (Mace)IBA 06/2022 - 01/2022
2	CeramidesIBA 03/2022 - 01/2018
2	PotassiumIBA 12/2021 - 06/2009
2	Bicarbonates (Hydrogen Carbonate)IBA 12/2021 - 11/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 09/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 11/2020
2	SteroidsIBA 01/2021 - 03/2011
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2018
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 12/2018
2	B7-H1 AntigenIBA 01/2020 - 12/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2018
2	Cinacalcet (Sensipar)FDA Link 01/2018 - 01/2012
2	AMP-Activated Protein KinasesIBA 01/2018 - 01/2018
2	EnzymesIBA 01/2018 - 05/2005
2	Adiponectin ReceptorsIBA 01/2018 - 01/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 08/2017 - 09/2014
2	Vitamin D FDA LinkGeneric 04/2015 - 01/2012
2	Biological ProductsIBA 12/2014 - 11/2010
2	Dialysis SolutionsIBA 09/2014 - 09/2014
2	AntioxidantsIBA 01/2014 - 06/2012
2	CholesterolIBA 12/2011 - 06/2010
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2011 - 11/2009
1	Acid CeramidaseIBA 03/2022
1	Lipocalin-2IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	HDL CholesterolIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Vasopressins (Vasopressin)IBA 06/2020
1	Inositol (Myoinositol)IBA 01/2020
1	Cystatin CIBA 01/2020

Therapy/Procedure

12	Renal Dialysis (Hemodialysis) 07/2019 - 01/2006
8	Kidney Transplantation 12/2019 - 03/2013
4	Therapeutics 01/2019 - 03/2011
3	Transplantation 11/2020 - 01/2011
3	Peritoneal Dialysis 01/2016 - 01/2013
2	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2020 - 03/2011
2	Hematopoietic Stem Cell Transplantation 07/2014 - 09/2013
1	Continuous Renal Replacement Therapy 01/2021
1	Remission Induction 01/2021
1	Heart Transplantation (Grafting, Heart) 11/2020
1	Extracorporeal Membrane Oxygenation 11/2020
1	Immunotherapy 01/2020